HUTCHMED HCM Rebounds 196 as Stock Approaches Key Resistance Level Motley Fool Highlights Biotech Stock as Potential FortuneMaker in Healthcare Sector NVST Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty Seven Stocks Poised for Sharp EarningsDriven Volatility Next Week